Comment

  • 8 March 2018

    Should we change how we think about diabetes?

    The push for a more personalized approach to diabetes management has been reenergized by recent research that suggests solely classifying diabetes into type 1 or type 2 diabetes (T1D, T2D)...

  • 28 February 2018

    Shire, Microsoft and EURORDIS form a strategic alliance

    Shire, a global biotechnology company focused on rare diseases, has formed a strategic alliance with Microsoft, a well-known technology company, and the European Organisation for Rare Diseases (EURORDIS)–Rare Diseases Europe,...

  • 27 February 2018

    UK tops European markets for diagnosis of early-stage CKD

    Chronic kidney disease (CKD) is a significant cause of morbidity and diminished quality of life for individuals with the disease. GlobalData epidemiologists analysed CKD epidemiology trends and found that the...

Go Top